Identification of hub genes and molecular subtypes in COVID-19 based on WGCNA

R-W Hu1, C Liu, Y-Y Yan

  • 1Department of Gastrointestinal Surgery, Henan Provincial People's Hospital, Zhengzhou, Henan, China. sry_lidan@sina.com.

Insights

Researchers identified three molecular subtypes of Coronavirus disease 2019 (COVID-19) with distinct gene activation patterns. These subtypes may explain the varied clinical presentations and outcomes observed in COVID-19 patients.

Area of Science:

  • Genomics
  • Molecular Biology
  • Infectious Diseases

Background:

  • Coronavirus disease 2019 (COVID-19) exhibits significant heterogeneity in clinical manifestations and mortality.
  • This variability may stem from underlying molecular differences within the patient population.
  • Identifying these molecular subtypes is crucial for improving disease management and patient outcomes.

Purpose of the Study:

  • To classify Coronavirus disease 2019 (COVID-19) patients into distinct molecular subtypes.
  • To identify key genes and biological pathways associated with each identified subtype.
  • To understand the molecular basis of clinical heterogeneity in COVID-19.

Main Methods:

  • Whole-genome sequencing data from COVID-19 patients and healthy controls were analyzed.
  • Consistent clustering was employed to classify patients into molecular subtypes.
  • Weighted gene co-expression network analysis (WGCNA) and differential gene expression analysis were performed.
  • Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were conducted.

Main Results:

  • Three distinct molecular subtypes of COVID-19 were identified.
  • Significant differences in gene activation and pathway enrichment were observed between subtypes.
  • Eleven hub genes, including RSAD2, IFIT1, and MX1, were identified as critical for differentiating subtypes.

Conclusions:

  • Distinct molecular subtypes of COVID-19 exist, characterized by unique gene activation profiles.
  • These molecular differences likely contribute to the observed heterogeneity in clinical symptoms and prognosis.
  • Understanding these subtypes offers potential for more targeted therapeutic strategies.
Abstract

Related Concept Videos

Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
16.8K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
14.7K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
9.2K